Instructions for use Frinol oral drops 50 ml
Composition
active ingredient:
100 g of oral drops contain: Frinol, liquid extract (1:11) from a mixture of LRS: gentian roots (Gentianae Radix), primrose flowers with a calyx (Primulae Flores cum Calycibus), sorrel grass (Rumicis Herba), elderflower flowers (Sambuci Flores), verbena grass (Verbenae Herba) (1:3:3:3:3) [extractant — ethanol 59% (v/v)] — 29.0 g;
Excipients: purified water.
Dosage form
Oral drops.
Main physicochemical properties: clear or slightly cloudy yellow-brown liquid. Turbidity or precipitation is possible during storage.
Pharmacotherapeutic group
Drugs used for coughs and colds. ATX code R05X.
Pharmacological properties
The components that make up the herbal medicine have complex activity, manifested in secretolytic action, anti-edematous, anti-inflammatory, immunostimulating and antiviral effects.
The active ingredients of the drug Frinol inhibit the reproduction of various respiratory viruses, such as influenza A virus, parainfluenza, and RSV (respiratory syncytial virus).
Under the influence of the drug, secretion is regulated and tissue edema is reduced. Drainage and ventilation of the paranasal sinuses are restored, nasal congestion is eliminated, the protective function of the respiratory tract epithelium is normalized. The effectiveness of antibiotic therapy is increased.
Frinol is a traditional herbal medicine for use according to indications confirmed by long-term use.
Indication
Acute and chronic inflammation of the paranasal sinuses.
Contraindication
Hypersensitivity to any of the active or auxiliary substances of the medicinal product, to other types of primrose. Peptic ulcer.
Interaction with other medicinal products and other types of interactions
No interactions with other drugs have been observed. Combination with antibiotics is possible and advisable.
Application features
It is recommended to consult a doctor if the patient experiences severe symptoms of rhinosinusitis, such as nosebleeds, fever, severe pain, purulent nasal discharge, visual disturbances, asymmetry of the midface or eyes, or facial numbness, as urgent medical treatment may be required.
If during treatment the patient's symptoms persist for more than 7–14 days, worsen, or recur periodically, the patient is advised to consult a doctor.
Special attention should be paid to the use of the drug in patients with gastritis or functional dyspepsia (the so-called "sensitive stomach"). The drug should be used after meals.
The medicine contains 19% (v/v) ethanol, i.e. 410 mg/dose, therefore it should not be used in patients who suffer from alcoholism or have successfully completed treatment for alcoholism.
Caution should be exercised when used in pregnant women, breastfeeding women, children, patients with liver disease, and those with epilepsy.
During storage, the drug may become cloudy or precipitate, but this does not affect the effect of the drug. Shake before use.
Use during pregnancy or breastfeeding
During pregnancy or breastfeeding, the drug can be used after consulting a doctor if the benefit of use outweighs the potential risk to the fetus/child.
The ability to influence the reaction speed when driving or working with other mechanisms
At recommended doses, the drug does not affect the ability to drive or operate other mechanisms, but it should be borne in mind that the drug contains ethanol.
Method of administration and doses
Unless otherwise prescribed by a doctor, the medicine should be used in the following doses:
| Age | Single dose | Daily dose |
|---|
| Children aged 2 to 5 years | 15 drops each, which is equivalent to 0.9 ml | 45 drops (3 times 15 drops), which is equivalent to 2.7 ml |
| Children aged 6 to 11 years | 25 drops each, which is equivalent to 1.5 ml | 75 drops (3 times 25 drops), which is equivalent to 4.5 ml |
| Children aged 12 and over and adults | 50 drops each, which is equivalent to 3 ml | 150 drops (3 times 50 drops), which is equivalent to 9 ml |
Adults usually take the drops undiluted, but if desired, a certain amount of liquid can be added. Children should use the drops diluted and, to hide the bitter taste, can be added to juice or tea.
The recommended course of treatment is usually 7–14 days, unless otherwise prescribed by your doctor. Please follow the recommendations in the "Special Instructions for Use" section of the instructions.
The patient should consult a doctor if the symptoms of the disease do not disappear while using the medicine or if any adverse reactions are observed.
Children
Due to lack of experience, the drug should not be used in children under 2 years of age.
Overdose
Cases of overdose are currently unknown. Exceeding the dose may increase the listed side effects.
Treatment: if signs of poisoning or overdose occur, symptomatic therapy is necessary.
Side effects
Gastrointestinal disorders, including stomach pain, nausea, diarrhea, vomiting, abdominal discomfort, are uncommon. Hypersensitivity reactions, including rash, skin redness, itching, urticaria, angioedema, shortness of breath, facial swelling, are possible.
If any adverse reactions occur, you should stop using the medicine and consult a doctor.
Expiration date
3 years.
The shelf life after opening the package is 6 months.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 ℃.
Keep out of reach of children.
Packaging
50 ml in a bottle, 1 bottle in a pack.
Vacation category
Without a prescription.
Producer
PJSC "Halychpharm".
Location of the manufacturer and address of its place of business
Ukraine, 79024, Lviv, Opryshkivska St., 6/8.
